108,803,656 133,755,071 (24,951,415) (18.66) Net Profit (Loss) (72,320,514) (72,280,526) (39,988) (0.06) Earnings per share (Baht per share) (0.015) (0.016) 0.001 6.25 Net Profit (Loss) The Company and
profit (loss) 267 114 153 134.0% EPS (THB) 0.316 0.135 0.181 134.0% Change Major Developments in 4Q17 The SEC approved the issuance and offering for sale of 409.4 million DREIT trust units as listed
)% Specialty Chemicals 40 158 (74)% 2 16 22 (90)% Core EBIT 598 1,000 (40)% 54 136 190 (72)% Core Net Profit after Tax and NCI4 387 789 (51)% 8 92 121 (93)% Core Net Profit after Tax and NCI (THB m) 12,002
subsidiaries (14.60) (9.03) 0.05 Profit(Loss) attributable to equity holders of the company (68.68) (42.47) (9.41) (38.21) (59.27) 629.86 Basic Loss Per Share (THB) (0.09) (0.02) Book Value per Share (THB) 0.46
1,494 8% EBITDA Bio-Based Product Business4/ 113 179 59 -48% -67% 259 238 -8% EBITDA Resource Business5/ 59 133 93 58% -30% 81 226 181% EBITDA Others 6/ (25) (25) (12) 54% 53% (25) (37) -48% Profit
million baht or 10.4 percent. The company reported profit for Q2/2017 of 4.9 million baht compared with reported loss for Q2/2016 of 6.1 million baht. For the six-month period of 2017, the consolidated
revenue for Q3/2017 of 95.0 million baht compared with Q3/2016 of 92.8 million baht, increased 2.2 million baht or 2.4 percent. The company reported profit for Q3/2017 of 4.7 million baht compared with
company reported loss for Q2/2018 of 6.2 million baht compared with reported profit for Q2/2017 of 4.9 million baht. For the six-month period of 2018, the consolidated revenue was 160.2 million baht
1,359 MB increased from 9M/2016 which was at 885 MB. However, the company’s performance was still impacted from Stock Loss and appreciating Baht currency which resulted in the reported net profit in